Publications

Efficient in vivo miRNA targeting of liver metastasis

Huynh, C., Segura, M. F., Gaziel-Sovran, A., Menendez, S., Darvishian, F., Chiriboga, L., Levin, B., Meruelo, D., Osman, I., Zavadil, J., Marcusson, E. G., & Hernando, E. (2011). Oncogene, 30(12), 1481–1488.

PMID: 21102518

Clinical relevance of SKP2 alterations in metastatic melanoma. Pigment Cell Melanoma Res

A.E. Rose, G. Wang, D. Hanniford, S Monni, T Tu, RL. Shapiro, RS. Berman, AC. Pavlick, M Pagano, F Darvishian, M Mazumdar, E Hernando, and I Osman.

24(1):197-206 (2011).

PMID: 20883453

The histone variant macroH2A suppresses melanoma progression through regulation of CDK8

Kapoor, A., Goldberg, M. S., Cumberland, L. K., Ratnakumar, K., Segura, M. F., Emanuel, P. O., Menendez, S., Vardabasso, C., Leroy, G., Vidal, C. I., Polsky, D., Osman, I., Garcia, B. A., Hernando, E., & Bernstein, E. (2010). Nature, 468(7327), 1105–1109.

PMID: 21179167

Profiling and Functional Analyses of MicroRNAs and Their Target Gene Products in Human Uterine Leiomyomas

J. Zavadil, H. Ye, Z. Liu, J. Wu, P. Lee, E. Hernando, P. Soteropoulos, GA Toruner, JJ Wei.

PLoS One, 5(8): e12362. (2010).

PMID: 20808773

A differentiation-based miRNA signature identifies leiomyosarcomas as a mesenchymal-stem cell related malignancy

L.S. Danielson, S. Menendez, C. Stephan-Otto Attolini, M.V. Guijarro, M. Bisogna, J.J. Wei, N.D. Socci, D.A. Levine, F. Michor and E. Hernando.

Am J Pathol. 177(2):908-17 (2010).

PMID: 20558575

MicroRNA signature predicts melanoma post-recurrence survival.

MF Segura, I Belitskaya-Lévy, AE Rose, J Zakrzewski, A Gaziel, D Hanniford, F Darvishian, I Osman, and E Hernando.

Clin Can Res 16(5): 1577-1586 (2010).

PMID: 2017923

Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research.

L Wich, H Hamilton, R Shapiro, A Pavlick, RS. Berman, D Polsky, J D. Goldberg, E Hernando, P. Manga, M Krogsgaard, H Kamino, F Darvishian, S Orlow, H Ostrer, N Bhardwaj, and I Osman.

Am J Transl Res. 1: 35-43 (2009).

PMID: 1996693

Aberrant miR-182 expression promotes melanoma metastasis by repressing Foxo3 and MITF.

MF Segura, D Hanniford, S Menendez, L Reavie, X Zou, S Alvarez-Diaz, J Zakrzewski, E Blochin, A Rose, D Bogunovic, D Polsky, JJ Wei, P Lee, I Belitskaya-Levy, N Bhardwaj, I Osman, and E Hernando.

PNAS 106 (6), 1814-1819 (2009).

PMID: 19188590